Recombinant Mycobacterium bovis Bacillus Calmette-Guérin Elicits Human Immunodeficiency Virus Type 1 Envelope-Specific T Lymphocytes at Mucosal Sites

A successful vaccine vector for human immunodeficiency virus type 1 (HIV-1) should induce anti-HIV-1 T-cell immune responses at mucosal sites. We have constructed recombinant Mycobacterium bovis bacillus Calmette-Guérin (rBCG) expressing an HIV-1 group M consensus envelope (Env) either as a surface,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Principais autores: Yu, Jae-Sung, Peacock, James W., Jacobs, William R., Frothingham, Richard, Letvin, Norman L., Liao, Hua-Xin, Haynes, Barton F.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology (ASM) 2007
Assuntos:
Vaccine Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1951062/
https://ncbi.nlm.nih.gov/pubmed/17507541
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.00407-06
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados